Catalyst Wire Dossier Catalyst Wire Dossier

Respimat inhaler

· Boehringer Ingelheim
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Respimat inhaler, covering 2014-07-14 to 2023-11-29. Get the full timeline:

Most recent: Clinical Trial Update: Flow Rate Effect Respimat Inhaler Versus a Metered Dose Inhaler Using Berodual in Patients With Chronic Obstructive Pulmonary Disease (COPD) [Phase 4]

See pricing